HIV vaccines show promising early results

Experimental HIV vaccines using mRNA technology have shown promising early results in both animal and human safety trials. The vaccines, tested in rabbits, monkeys, and over 100 human volunteers, triggered potent immune responses and demonstrated fewer side effects compared to previous approaches. These advancements, published in Science Translational Medicine, offer hope for a new preventative tool against HIV, though further research is needed to confirm efficacy and address side effects like hives.